Uterine
Uterus
Leiomyoma (fibroids)
MC in black pts
Hormone sensitive neoplasms (benign) of smooth muscle and C.T.
MC tumor of ♀ GU
RF: early menarche, nulliparity, obesity, family hx
SSX
Abnormal menstruation ↑ bleeding with periods ➔ anemia
Mass effect ➔ back pain, pelvic/fullness, constipation, LUTS can ➔ hydronephrosis
Dyspareunia, infertility
DX
US: hypoechoic, heterogeneous tumors
Calcifications suggest necrosis and may be seen on CT/X-ray
Hysteroscopy or saline infused US can better visualize submucosal fibroids
TX
ASX/incidental finding do not require tx and will ↓ with ↓ estrogen (menopause)
SX TX
Dual oral contraceptives ➔ ↓ bleeding/pain but can ↑ leiomyoma size
F/u US q 6mo
Leuprolide (GnRH agonist) for no more than 6mo to shrink tumor
Myomectomy - surgical removal of fibroids (preserves fertility)
Definitive TX is hysterectomy (no urge to conceive in future/postmenopausal)
Submucosal > intramural in causing infertility
Endometriosis
MC in white pts
Endometrial tissue outside uterus (ovaries (MC) anterior bladder, bowel)
Hormone sensitive
Endometrial cells seeding may play a role
Iatrogenic implantation (episiotomy/laparotomy)
Retrograde menstruation (menstrual backflow)
SSX
Dysmenorrhea (pain ↑ during periods)
Back pain, rectovaginal tenderness
Dyschezia (painful BM), infertility, pelvic pain/fullness
Can ➔ adhesions
DX
Trans-vag US shows ovarian chocolate cysts
Cyst with hemorrhagic debris ➔ homogeneous ground-glass
Laparoscopy confirms
Large black/blue spots (large lesions or powder burn)
± Bladder/rectovaginal nodules
TX
NSAIDs and dual oral contraceptives
Danazol (ADR ➔ ♂ sex features)
Leuprolide (GnRH agonist) with DOC to inhibit ADR of ↓estrogen
Goserelin will force menopause
Refractory ➔ surgery
No urge to conceive in future/postmenopausal:
Ablation or artery ligation
Hysterectomy
Adenomyosis
Benign growth of endometrial tissue into myometrium
In the DfDX of endometriosis
MC 35-50yo
RF: Endometriosis, fibroids
SSX
Dysmenorrhea, bleeding, pelvic pain affected by menses
Globular, soft, enlarged but tender uterus
DX
Myometrial wall thickening (asymmetric)
TX
DOC or progestin only
Endometrial hyperplasia
↑ estrogen ➔ ↑ proliferation
PCOS, hormone replacement therapy
Without atypia has low risk of carcinoma
With atypia has ↑ ↑ risk of carcinoma
SSX
Bleeding/spotting
DX
US to assess endometrial thickening: >4mm in postmenopausal, >15mm in premenopausal
Still menstruating endometrium ranges from 3-15mm
Endometrial biopsy
FSH, estrogen to investigate other source of estrogen (ovarian tumors)
TX
Without atypia: Progestin only (from d12-25 of cycle if premenopausal) and f/u every 3-6mo with US
With atypia: Total hysterectomy with bilateral salpingo oophorectomy (TAH/BSO) if no urge to have children
Endometrial Cancer (Adenocarcinoma)
MC 65-74yo
↑ estrogen or SERM for breast cancer ➔ atypical endometrial hyperplasia ➔ endometrioid adenocarcinoma
Multiparity, dual oral contraceptives is protective
Contiguous spread, LN later, rarely hematogenic mets to lungs
TYPE 1: from prolonged estrogen exposure ➔ hyperplasia
TYPE 2: stronger genetic component
SSX
Painless vaginal bleeding is endometrial cancer until proven otherwise
Peri/premenopausal: metorrhagia (heavy bleeding between periods)
Seen incidentally on pelvic US - endometrial stripe
DX: Endometrial biopsy
TX
Stage 1 cancer: TAH/BSO with pelvic and para-aortic LN sampling ± radiation
Stage 2 cancer: TAH/BSO with LN excision ± and radiation
Abnormal Uterine Bleeding
Heavy menstrual/intermenstrual bleeding
Structural (PALM): Polyp, adenomyosis, leiomyoma, malignancy/hyperplasia
Nonstructual (COEIN): Coagulopathy, ovulatory, endometrial, iatrogenic, not yet classified
DX
HCG, CBC, TSH, FSH/LH
Endometrial biopsy if >45yo
TVUS first
TX
Dual oral contraceptives, progestins
Severe AUB:
Uterine curettage first
Refractory bleeding ➔ IV conjugated equine estrogen
Refractory to IV estrogen ➔ hysterectomy